Search Results - "Thompson, Miles"

Refine Results
  1. 1

    Innovations in Phenotyping and Diagnostics Create Opportunities for Improved Treatment and Genetic Counseling for Rare Diseases by Thompson, Miles D

    Published in Genes (01-06-2024)
    “…Genetic counseling and treatment options for rare developmental disabilities (DDs) have been revolutionized by the opportunities made possible by using…”
    Get full text
    Journal Article
  2. 2

    Rare Genetic Developmental Disabilities: Mabry Syndrome (MIM 239300) Index Cases and Glycophosphatidylinositol (GPI) Disorders by Thompson, Miles D, Knaus, Alexej

    Published in Genes (14-05-2024)
    “…The case report by Mabry et al. (1970) of a family with four children with elevated tissue non-specific alkaline phosphatase, seizures and profound…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics by Thompson, Miles D, Sakurai, Takeshi, Rainero, Innocenzo, Maj, Mary C, Kukkonen, Jyrki P

    Published in Pharmaceuticals (Basel, Switzerland) (08-10-2017)
    “…Orexins/hypocretins are neuropeptides formed by proteolytic cleavage of a precursor peptide, which are produced by neurons found in the lateral hypothalamus…”
    Get full text
    Journal Article
  5. 5

    Antiseizure effects of the cannabinoids in the amygdala‐kindling model by Fallah, Merrick S., Dlugosz, Lukasz, Scott, Brian W., Thompson, Miles D., Burnham, W. McIntyre

    Published in Epilepsia (Copenhagen) (01-09-2021)
    “…Objective Focal impaired awareness seizures (FIASs) are the most common seizure type in adults and are often refractory to medication. Management of FIASs is…”
    Get full text
    Journal Article
  6. 6

    Variation in the Serotonin Transporter Gene and Alcoholism: Risk and Response to Pharmacotherapy by Thompson, Miles D, Kenna, George A

    Published in Alcohol and alcoholism (Oxford) (01-03-2016)
    “…SLC6A4, the gene encoding the serotonin transporter protein (5-HTT), has been extensively examined as a risk factor for alcohol dependence (AD). More recently,…”
    Get full text
    Journal Article
  7. 7
  8. 8

    OX1 and OX2 orexin/hypocretin receptor pharmacogenetics by Thompson, Miles D, Xhaard, Henri, Sakurai, Takeshi, Rainero, Innocenzo, Kukkonen, Jyrki P

    Published in Frontiers in neuroscience (06-05-2014)
    “…Orexin/hypocretin peptide mutations are rare in humans. Even though human narcolepsy is associated with orexin deficiency, this is only extremely rarely due to…”
    Get full text
    Journal Article
  9. 9

    G protein-coupled receptor (GPCR) gene variants and human genetic disease by Thompson, Miles D, Percy, Maire E, Cole, David E C, Bichet, Daniel G, Hauser, Alexander S, Gorvin, Caroline M

    “…Genetic variations in the genes encoding G protein-coupled receptors (GPCRs) can disrupt receptor structure and function, which can result in human genetic…”
    Get full text
    Journal Article
  10. 10

    G protein-coupled receptor (GPCR) pharmacogenomics by Thompson, Miles D, Reiner-Link, David, Berghella, Alessandro, Rana, Brinda K, Rovati, G Enrico, Capra, Valerie, Gorvin, Caroline M, Hauser, Alexander S

    “…The field of pharmacogenetics, the investigation of the influence of one or more sequence variants on drug response phenotypes, is a special case of…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends by Capra, Valérie, Thompson, Miles D., Sala, Angelo, Cole, David E., Folco, Giancarlo, Rovati, G. Enrico

    Published in Medicinal research reviews (01-07-2007)
    “…Cysteinyl‐leukotrienes (cysteinyl‐LTs), that is, LTC4, LTD4, and LTE4, trigger contractile and inflammatory responses through the specific interaction with G…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies by Thompson, Miles D, Capra, Valerie, Clunes, Mark T, Rovati, G E, Stankova, Jana, Maj, Mary C, Duffy, David L

    Published in Frontiers in pharmacology (01-12-2016)
    “…Genetic variants associated with asthma pathogenesis and altered response to drug therapy are discussed. Many studies implicate polymorphisms in genes encoding…”
    Get full text
    Journal Article
  18. 18

    Acceptance and Related Processes in Adjustment to Chronic Pain by Thompson, Miles, McCracken, Lance M.

    Published in Current pain and headache reports (01-04-2011)
    “…Chronic pain poses significant challenges in the lives of many people. At the root of many of these challenges are the behavior patterns pain naturally…”
    Get full text
    Journal Article
  19. 19

    G protein-coupled receptor mutations and human genetic disease by Thompson, Miles D, Hendy, Geoffrey N, Percy, Maire E, Bichet, Daniel G, Cole, David E C

    “…Genetic variations in G protein-coupled receptor genes (GPCRs) disrupt GPCR function in a wide variety of human genetic diseases. In vitro strategies and…”
    Get more information
    Journal Article
  20. 20

    Cellular signalling of cysteinyl leukotriene type 1 receptor variants CysLT1 -G300S and CysLT1 -I206S by Yaddaden, Louiza, Véronneau, Steeve, Thompson, Miles D, Rola-Pleszczynski, Marek, Stankova, Jana

    “…Abstract Cysteinyl-leukotrienes are pro-inflammatory lipid mediators, involved in allergic asthma, that bind the G-protein-coupled receptors CysLT1 , CysLT2…”
    Get full text
    Journal Article